Form 8-K - Current report:
SEC Accession No. 0001564590-21-059372
Filing Date
2021-12-06
Accepted
2021-12-06 06:30:40
Documents
38
Period of Report
2021-12-06
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K agle-8k_20211206.htm   iXBRL 8-K 53552
2 EX-99.1 agle-ex991_28.htm EX-99.1 29546
3 EX-99.2 agle-ex992_147.htm EX-99.2 26588
4 GRAPHIC slide-mo5tfpegcu4.jpg GRAPHIC 141103
5 GRAPHIC slide-ojr4levsm3f.jpg GRAPHIC 94784
6 GRAPHIC slide-jtw23ebcvkf.jpg GRAPHIC 171709
7 GRAPHIC gha3atnnxwsy000001.jpg GRAPHIC 12575
8 GRAPHIC slide-tz5nou1yptn.jpg GRAPHIC 149639
9 GRAPHIC slide-gtg2euwzzjb.jpg GRAPHIC 141055
10 GRAPHIC slide-a3e2cyb0q4r.jpg GRAPHIC 206787
11 GRAPHIC slide-24mza2sunvo.jpg GRAPHIC 105049
12 GRAPHIC slide-dm1mp5t21qs.jpg GRAPHIC 225552
13 GRAPHIC slide-ehdgemusqv5.jpg GRAPHIC 76263
14 GRAPHIC slide-u1gxtflfgy0.jpg GRAPHIC 144854
15 GRAPHIC slide-4uimyeplrx4.jpg GRAPHIC 130938
16 GRAPHIC slide-t5ppvkybg5s.jpg GRAPHIC 225586
17 GRAPHIC slide-lszepxpd3hk.jpg GRAPHIC 159320
18 GRAPHIC slide-j1pwzhebhf3.jpg GRAPHIC 190665
19 GRAPHIC slide-uwveqs3f0x0.jpg GRAPHIC 138189
20 GRAPHIC slide-4pocg40jvqi.jpg GRAPHIC 60156
21 GRAPHIC slide-n0aopc5lvlk.jpg GRAPHIC 390384
22 GRAPHIC slide-0j1yqvmk5cb.jpg GRAPHIC 216613
23 GRAPHIC slide-4sj5wxhzpdm.jpg GRAPHIC 143366
24 GRAPHIC slide-fvjcigqzrvj.jpg GRAPHIC 292249
25 GRAPHIC slide-f3siydogjqi.jpg GRAPHIC 188297
26 GRAPHIC slide-0x32df2nn01.jpg GRAPHIC 150276
27 GRAPHIC slide-l20nei2axmg.jpg GRAPHIC 183445
  Complete submission text file 0001564590-21-059372.txt   5692231

Data Files

Seq Description Document Type Size
28 XBRL TAXONOMY EXTENSION SCHEMA agle-20211206.xsd EX-101.SCH 5673
29 XBRL TAXONOMY EXTENSION LABEL LINKBASE agle-20211206_lab.xml EX-101.LAB 20080
30 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agle-20211206_pre.xml EX-101.PRE 11927
31 EXTRACTED XBRL INSTANCE DOCUMENT agle-8k_20211206_htm.xml XML 3683
Mailing Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746
Business Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37722 | Film No.: 211471882
SIC: 2834 Pharmaceutical Preparations